Foreign-invested pharmaceutical firms remain concerned about successive cost cutting measures

Published: 2002-09-25 06:59:00

Updated: 2002-09-25 06:59:00

In parallel with a series of the government measures aimed at reducing pharmaceutical spending for better finance stability in the National Health Insurance Corp., including a drug price re-evaluation system, a minimum drug price system, and restricted reimbursement, foreign-invested pharmaceutic...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK